Bronchiolitis epidemiology after the COVID-19 pandemic: a partial return toward pre-pandemic patterns? An Italian surveillance study

The COVID-19 pandemic and related interventions disrupted the typical seasonal patterns of bronchiolitis, leading to a significant decline in hospitalizations and disease severity. However, during the 2022–2023 winter season, bronchiolitis cases surged, with both the number of hospitalizations and disease severity exceeding pre-pandemic levels. Given these fluctuations, we considered it crucial to monitor the burden of bronchiolitis, particularly in light of the upcoming universal respiratory syncytial virus prophylactic antibody coverage in Italy. We retrospectively evaluated bronchiolitis-related hospitalizations and disease severity in infants (< 1 year) during winter seasons (September 1st to March 31st) across seven Italian hospitals from 2018 to 2019 through 2023–2024. A total of 833 infants were hospitalized for bronchiolitis during the 2023–2024 winter season across the seven participating hospitals, decreasing from 1102 in 2022–2023 and representing the first decline since the 2021–2022 season. The proportion of tested infants who were RSV-positive did not differ significantly between 2023 and 2024 and 2022–2023 (82% vs. 79%); the fall in RSV-positive admissions therefore mirrored the overall decline in hospitalization numbers rather than a reduction in RSV positivity. Compared with 2022–2023, a significantly smaller proportion of infants required oxygen supplementation, high-flow nasal cannula, or intensive care unit admission, although the duration of respiratory support among infants who required it did not decrease and was, if anything, marginally longer. Hospital length of stay did not differ significantly between the two seasons. Several indicators - including RSV positivity and the proportion of infants requiring oxygen or high-flow nasal cannula - remained significantly higher than pooled pre-pandemic (2018–2020) values, while the proportion requiring intensive care unit admission had returned to a level statistically similar to the pre-pandemic period. Our findings indicate a partial return toward pre-pandemic bronchiolitis epidemiology during the 2023–2024 winter season, with fewer infants requiring escalated respiratory support than in 2022–2023, although several indicators remained above pre-pandemic levels. Continued monitoring remains important, particularly in anticipation of the upcoming respiratory syncytial virus prophylactic antibody program in Italy.

Authors

Institutions

Publication Details

Journal
The Italian Journal of Pediatrics/Italian journal of pediatrics
Published
2026-11-18
DOI
https://doi.org/10.1186/s13052-026-02381-9
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bronchiolitis epidemiology after the COVID-19 pandemic: a partial return toward pre-pandemic patterns? An Italian surveillance study

Alessandro Amaddeo, Salvatore Aversa, Marta Minute, Anna Chiara Vittucci et al.
4 links
The Italian Journal of Pediatrics/Italian journal of pediatrics
Respiratory viral infections research
article

Bronchiolitis epidemiology after the COVID-19 pandemic: a partial return toward pre-pandemic patterns? An Italian surveillance study

Alessandro Amaddeo, Salvatore Aversa, Marta Minute, Anna Chiara Vittucci, Laura Dotta, Nicola Ullmann, Alessandro Zago, Renato Cutrera, Alessia Rocchi, Francesca Castelletti, Michele Ghezzi, Alessandro De Fanti, Sergio Ghirardo, Enza D’Auria, Maria Francesca Patria, Barbara Madini, Egidio Barbi, Raffaele Badolato, Beatrice Andrenacci, Andrea Trombetta, Vincenzo Guaia, Stefano Martelossi, Sara Procoli, Francesca Maria Risso
article en

Abstract

The COVID-19 pandemic and related interventions disrupted the typical seasonal patterns of bronchiolitis, leading to a significant decline in hospitalizations and disease severity. However, during the 2022–2023 winter season, bronchiolitis cases surged, with both the number of hospitalizations and disease severity exceeding pre-pandemic levels. Given these fluctuations, we considered it crucial to monitor the burden of bronchiolitis, particularly in light of the upcoming universal respiratory syncytial virus prophylactic antibody coverage in Italy. We retrospectively evaluated bronchiolitis-related hospitalizations and disease severity in infants (< 1 year) during winter seasons (September 1st to March 31st) across seven Italian hospitals from 2018 to 2019 through 2023–2024. A total of 833 infants were hospitalized for bronchiolitis during the 2023–2024 winter season across the seven participating hospitals, decreasing from 1102 in 2022–2023 and representing the first decline since the 2021–2022 season. The proportion of tested infants who were RSV-positive did not differ significantly between 2023 and 2024 and 2022–2023 (82% vs. 79%); the fall in RSV-positive admissions therefore mirrored the overall decline in hospitalization numbers rather than a reduction in RSV positivity. Compared with 2022–2023, a significantly smaller proportion of infants required oxygen supplementation, high-flow nasal cannula, or intensive care unit admission, although the duration of respiratory support among infants who required it did not decrease and was, if anything, marginally longer. Hospital length of stay did not differ significantly between the two seasons. Several indicators - including RSV positivity and the proportion of infants requiring oxygen or high-flow nasal cannula - remained significantly higher than pooled pre-pandemic (2018–2020) values, while the proportion requiring intensive care unit admission had returned to a level statistically similar to the pre-pandemic period. Our findings indicate a partial return toward pre-pandemic bronchiolitis epidemiology during the 2023–2024 winter season, with fewer infants requiring escalated respiratory support than in 2022–2023, although several indicators remained above pre-pandemic levels. Continued monitoring remains important, particularly in anticipation of the upcoming respiratory syncytial virus prophylactic antibody program in Italy.

The Italian Journal of Pediatrics/Italian journal of pediatrics
University of Trieste (IT), IRCCS Materno Infantile Burlo Garofolo (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Bambino Gesù Children's Hospital (IT), Ospedale dei Bambini Vittore Buzzi (IT), Ca' Foncello Hospital (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Brescia (IT)
Ministero della Salute
Good health and well-being
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon